The 2025 impact factor for Cancer Radiotherapie is 1.4. The 5-year impact factor is 1.2. The journal is listed as JCR Q3 in the current Journal Metrics dataset.
Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.
If you searched for Cancer Radiotherapie impact factor 2025, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.
This page is designed for exact-title searches such as Cancer Radiotherapie impact factor 2025. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.
For high-stakes submission decisions, verify the title against the publisher record at the journal homepage, Clarivate's Master Journal List or Journal Citation Reports if you have access, and the context in our methodology. Treat the 5-year impact factor, JCR quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.
Ranked #993 in Oncology by impact factor and #212 among Q3 Oncology journals. This context helps compare Cancer Radiotherapie against journals publishing in the same field.
Published 451 papers across the last 5 recorded years with a current impact factor of 1.4.
See if your manuscript fits this journal's recent focus before you commit to a shortlist.